Ausgabe 10/2011
Inhalt (7 Artikel)
Open Access
Review
Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors
William H. Ludlam, Lowell Anthony
Open Access
Review
Unapproved drugs in the united states and the food and drug administration
Alexander Nasr, Thomas J. Lauterio, Matthew W. Davis
Original Research
Pharmacokinetic pilot study of the antiangiogenic activity of standardized platycodi radix
Emma M. Twiner, Zhijun Liu, Jeffrey Gimble, Ying Yu, Frank Greenway
Original Research
Efficacy of cilostazol for intracranial arterial stenosis evaluated by digital subtraction angiography/magnetic resonance angiography
Keiichi Yamada, Yasuhiro Fujimoto
Original Research
Long-term safety and efficacy of the recombinant human growth hormone omnitrope® in the treatment of Spanish growth hormone deficient children: Results of a phase III study
J. López-Siguero, V. Borrás Pérez, S. Balser, J. Khan-Boluki
Open Access
Original Research
The “MESACA” study: Methylsulfonylmethane and boswellic acids in the treatment of gonarthrosis
Angela Notarnicola, Silvio Tafuri, Lucrezia Fusaro, Lorenzo Moretti, Vito Pesce, Biagio Moretti
Original Research
Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors
Alpesh N. Amin, Mehul Jhaveri, Jay Lin